文献速递重症综合管理与镇静镇痛消化、代谢与肾脏急症

脓毒症中白蛋白与纤维蛋白原的动力学:一项前瞻性观察性研究

Albumin and fibrinogen kinetics in sepsis: a prospective observational study.
PubMed 文献 · Crit Care · 2021-12-17
一句话结论脓毒症患者白蛋白水平降低但合成速率与非脓毒症患者相当,提示低白蛋白血症源于清除增加而非肝合成受抑;纤维蛋白原升高源于合成增加。

该前瞻性观察性研究采用稳定同位素L-[ring-2H5]苯丙氨酸输注,测量脓毒症机械通气患者与非脓毒症择期冠状动脉旁路移植术患者的白蛋白和纤维蛋白原动力学。结果显示脓毒症患者平均血浆白蛋白较非脓毒症患者降低,但白蛋白绝对合成速率两组相当;脓毒症患者平均血浆纤维蛋白原和绝对合成速率均较非脓毒症患者升高。非脓毒症患者血浆白蛋白与绝对合成速率无统计学显著相关,而血浆纤维蛋白原与绝对合成速率显著相关;脓毒症患者血浆白蛋白和纤维蛋白原均与绝对合成速率显著相关。结论提示脓毒症低白蛋白血症非肝合成受抑所致,而是循环清除增加的结果;高纤维蛋白原血症源于纤维蛋白原生成增加。

要点

  • 脓毒症机械通气患者平均血浆白蛋白低于非脓毒症患者,但白蛋白绝对合成速率两组相当。
  • 脓毒症患者平均血浆纤维蛋白原和纤维蛋白原绝对合成速率均高于非脓毒症患者。
  • 脓毒症患者血浆白蛋白和纤维蛋白原均与各自绝对合成速率显著相关。
  • 非脓毒症患者血浆白蛋白与绝对合成速率无统计学显著相关,血浆纤维蛋白原与绝对合成速率显著相关。
  • 作者认为脓毒症低白蛋白血症是循环清除增加的结果,而非肝合成受抑;高纤维蛋白原血症源于生成增加。

适用人群与场景

  • 机械通气的脓毒症患者,以及计划择期冠状动脉旁路移植术的非脓毒症患者(非脓毒症组于手术前一天进行研究)。
  • 研究经机构研究伦理委员会批准,并获得患者或其替代决策者的书面知情同意。

处置流程与药物剂量

  • 采用稳定同位素L-[ring-2H5]苯丙氨酸测量白蛋白和纤维蛋白原的绝对合成速率。
  • 给予L-[ring-2H5]苯丙氨酸负荷剂量4 µmol/kg,随后以0.15 µmol/kg/min速率输注6小时。
  • 基线和之后每小时抽血,通过气相色谱/质谱法测量同位素富集度。
  • 采用极低密度脂蛋白载脂蛋白B 100同位素富集度代表肝脏合成蛋白的苯丙氨酸前体池同位素富集度。
  • 同时测量血浆白蛋白和纤维蛋白原浓度。

研究设计与关键结果

  • 研究类型:前瞻性观察性研究;人群:机械通气的脓毒症患者与非脓毒症择期冠状动脉旁路移植术患者;干预:稳定同位素L-[ring-2H5]苯丙氨酸输注;主要终点:白蛋白和纤维蛋白原动力学。
  • 脓毒症患者平均血浆白蛋白较非脓毒症患者降低,但白蛋白绝对合成速率两组相当。
  • 脓毒症患者平均血浆纤维蛋白原和纤维蛋白原绝对合成速率均较非脓毒症患者升高。
  • 非脓毒症患者血浆白蛋白与绝对合成速率无统计学显著相关,血浆纤维蛋白原与绝对合成速率显著相关。
  • 脓毒症患者血浆白蛋白和纤维蛋白原均与绝对合成速率显著相关。

证据类型、等级与局限

  • 证据类型:前瞻性观察性研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,脓毒症患者低白蛋白血症不是肝合成受抑所致,而是循环清除增加的结果。
  • 作者认为,脓毒症患者高纤维蛋白原血症是纤维蛋白原生成增加的结果。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: The measurement of circulating substrate concentrations does not provide information about substrate kinetics. It, therefore, remains unclear if a decrease in plasma concentration of albumin, as seen during critical illness, is a consequence of suppressed production in the liver or increased peripheral clearance. In this study, using stable isotope tracer infusions, we measured albumin and fibrinogen kinetics in septic patients and in a control group of non-septic subjects.

METHODS: With the approval from the institutional Research Ethics Board and after obtaining written informed consent from patients or their substitute decision maker, mechanically ventilated patients with sepsis and patients scheduled for elective coronary artery bypass grafting were enrolled. Patients in the non-sepsis group were studied on the day before surgery. The stable isotope L-[ring-2H5]phenylalanine was used to measure absolute synthesis rates (ASR) of albumin and fibrinogen. A priming dose of L-[ring-2H5]phenylalanine (4 µmol/kg) was given followed by a six-hour infusion at a rate of 0.15 µmol/kg/min. At baseline and hourly thereafter, blood was drawn to measure isotope enrichments by gas chromatography/mass spectrometry. Very low density lipoprotein apolipoprotein-B 100 isotopic enrichment was used to represent the isotopic enrichment of the phenylalanine precursor pool from which the liver synthesizes proteins. Plasma albumin and fibrinogen concentrations were also measured.

RESULTS: Mean plasma albumin in septic patients was decreased when compared to non-septic patients, while synthesis rates were comparable. Mean plasma fibrinogen and ASR in septic patients was increased when compared to non-septic patients. In non-septic patients, no statistically significant correlation between plasma albumin and ASR was observed but plasma fibrinogen significantly correlated with ASR. In septic patients, plasma albumin and fibrinogen significantly correlated with ASR.

CONCLUSIONS: While septic patients showed lower plasma albumin levels than non-septic patients, albumin synthesis was similar in the two groups suggesting that hypoalbuminemia during sepsis was not caused by suppressed hepatic production but a result of enhanced clearance from the circulation. Hyperfibrinogenemia in septic patients was a consequence of increased fibrinogen production.

TRIAL REGISTRATION: ClinicalTrials.gov: NCT02865408 (registered on August 12, 2016) and ClinicalTrials.gov: NCT02549443 (registered on September 15, 2015).

来源:Crit Care,查看原文。版权归原作者所有。

参考来源

  1. Omiya K, Sato H, Sato T, et al. Albumin and fibrinogen kinetics in sepsis: a prospective observational study. Crit Care. 2021. PMID: 34920728. doi:10.1186/s13054-021-03860-7

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。